Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15194018 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)
Condition: Hypercholesterolemia
Interventions: Drug: MK0653, ezetimibe / Duration of Treatment: 28 weeks;   Drug: Comparator: atorvastatin / Duration of Treatment: 28 weeks

Indicates status has not been verified in more than two years